Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Galapagos NV    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about GALAPAGOS NV
11/30GALAPAGOS : reports positive topline results with GLPG1205 in IPF patients in PI..
AQ
11/30Galapagos reports positive topline results with GLPG1205 in IPF patients in P..
GL
11/23GALAPAGOS : Selvita to acquire Fidelta from Galapagos
AQ
11/23GALAPAGOS : Selvita to acquire Fidelta from Galapagos
AQ
11/09GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria..
AQ
11/09GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria..
AQ
11/09First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial
GL
11/05GALAPAGOS : OncoArendi and Galapagos enter into exclusive collaboration on chiti..
AQ
11/05GALAPAGOS : OncoArendi and Galapagos enter into exclusive collaboration on chiti..
AQ
11/05OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhi..
GL
11/05GALAPAGOS : reports Q3 2020 results
AQ
11/05GALAPAGOS : reports Q3 2020 results
AQ
11/05Galapagos reports Q3 2020 results
GL
11/02GALAPAGOS : European Medicines Agency Validates Marketing Application for Filgot..
BU
11/02GALAPAGOS : European  medicines  agency  validates  marketing  application  for ..
AQ
More most relevant news
All news about GALAPAGOS NV
11/30GALAPAGOS : reports positive topline results with GLPG1205 in IPF patients in PI..
AQ
11/30Galapagos reports positive topline results with GLPG1205 in IPF patients in P..
GL
11/23GALAPAGOS : Selvita to acquire Fidelta from Galapagos
AQ
11/23GALAPAGOS : Selvita to acquire Fidelta from Galapagos
AQ
11/09GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria..
AQ
11/09GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria..
AQ
11/09First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial
GL
11/09OXURION NV Confirms New Patents for THR-687 Issued by European and US Patent ..
AQ
11/05GALAPAGOS : OncoArendi and Galapagos enter into exclusive collaboration on chiti..
AQ
11/05GALAPAGOS : OncoArendi and Galapagos enter into exclusive collaboration on chiti..
AQ
More news
News in other languages on GALAPAGOS NV
11/09AVIS D'ANALYSTES DU JOUR : Amadeus, Cellnex, Eurazeo, Givaudan, Kering, Klépierr..
10/21AVIS D'ANALYSTES DU JOUR : Air Liquide, Continental, Galapagos, Logitech, Superd..
10/01TOUR DU MONDE DES INDICES : l’Aristocratie souffre sur le S&P500, la Santé sauve..
09/21TOUR DU MONDE DES INDICES : Les secteurs sont à l’honneur
08/25Vaccin, Chine, Election, le décor est planté
08/25AVIS D'ANALYSTES DU JOUR : Aperam, ArgenX, Barco, Galapagos, Melexis, Esker, Soi..
08/19GALAPAGOS NV : -26% après la position inattendue de la FDA sur filgotinib
08/19AVIS D'ANALYSTES DU JOUR : Ambu, Cellectis, Clariant, Demant, Geberit, JCDecaux,..
06/08GALAPAGOS : données positives dans l'arthrite psoriasique
05/22AVIS D'ANALYSTES DU JOUR : Altice Europe, Compass, Intertek, LafargHolcim, Moncl..
Analyst Recommendations on GALAPAGOS NV
03/30European shares reverse course to end higher on defensive plays
RE
2019Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
2019Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
2018Galapagos, Gilead bask in $4-6 billion new drug sales hope
RE
2017Cyclicals and ex-divs send European shares to four-month low
RE
More recommendations
Press releases
11/30GALAPAGOS : reports positive topline results with GLPG1205 in IPF patients in PI..
AQ
11/30Galapagos reports positive topline results with GLPG1205 in IPF patients in P..
GL
11/23GALAPAGOS : Selvita to acquire Fidelta from Galapagos
AQ
11/23GALAPAGOS : Selvita to acquire Fidelta from Galapagos
AQ
11/09GALAPAGOS : First patient dosed with GLPG3667 in psoriasis patient Phase 1b tria..
AQ
More press releases
Analysis
Gilead shares slide after FDA knocks back rheumatoid arthritis drug
Stock Trading Strategies
TRADING
 A support level that should be taken advantage of
Official Publications
09/303rd quarter report 
06/30Half-year report 
06/30Half-year report 
05/28Crossing thresholds 
05/28Crossing thresholds 
04/28Proxy Statments 
Upcoming event on GALAPAGOS NV
12/03/20Berenberg European Conference
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers Best of des tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2020 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ